Alnylam Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Alnylam Pharmaceuticals patents 133 in total
| Status | Patent |
|---|---|
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: MYOSTATIN IRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: LACTATE DEHYDROGENASE A (LDHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: POLYNUCLEOTIDE AGENTS TARGETING COMPLEMENT COMPONENT C5 AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: QUANTIFICATION OF TRANSTHYRETIN AND ITS ISOFORMS Filling date: 9 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS FOR THE TREATMENT OF SUBJECTS HAVING A HEPATITIS B VIRUS (HBV) INFECTION Filling date: 9 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 9 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT Filling date: 9 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS Filling date: 9 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: MODIFIED iRNA AGENTS Filling date: 9 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES Filling date: 9 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: ENDOSOMAL CLEAVABLE LINKERS Filling date: 9 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: Compositions and Methods for Inhibiting Expression of Transthyretin Filling date: 9 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: ASSAYS AND METHODS FOR DETERMINING ACTIVITY OF A THERAPEUTIC AGENT IN A SUBJECT Filling date: 9 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 9 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES Filling date: 9 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: COMPOSITIONS AND METHODS FOR THE MANUFACTURE OF LIPID NANOPARTICLES Filling date: 9 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: THERAPEUTIC COMPOSITIONS Filling date: 9 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: GLYCOCONJUGATES OF RNA INTERFERENCE AGENTS Filling date: 9 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) Filling date: 9 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: MODIFIED DOUBLE-STRANDED RNA AGENTS Filling date: 9 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: MODIFIED DOUBLE-STRANDED RNA AGENTS Filling date: 9 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING INSECTS Filling date: 9 Sep 2025 Issue date: 1 Aug 2019 |
Showing 100 to 133 of 133 patents.